UCB Biopharma

• A study to learn if UCB3101 is safe and how it moves through the body of healthy participants Ended
  2023-504586-24-00 Phase I 1 country
• An extension of the orchestra (PD0053) study to learn how safe minzasolmin is and if it works long-term in participants with Parkinson’s dis… Ended
  2022-500424-30-00 Phase II 6 countries MINZASOLMIN
• A study to learn if brivaracetam works and is safe in children and young adults 2 to 25 years of age with childhood absence epilepsy or juve… Ended
  2023-510428-55-00 Phase II/III 4 countries BRIVARACETAM
• A study to learn if bepranemab is safe and works in people with early stages of Alzheimer’s Disease Ended
  2023-506170-12-00 Phase II 7 countries 2-(4-(2-[18F]FLUORO-2,2-DIDEUTERO ETHYL)PIPERIDIN-1-YL)BENZO[4,5]IMIDAZO[1,2-A]P…
• A study to learn how safe bimekizumab, how well it works and how it moves through the bloodstream in adolescents with moderate to severe pla… Ended
  2023-509832-24-00 Phase II 2 countries BIMEKIZUMAB
• An extension study to learn if Bimekizumab is safe and works as a long-term therapy in adults with moderate to severe hidradenitis suppurati… Ended
  2024-511035-10-00 Phase III 9 countries BIMEKIZUMAB
• A study to learn if lacosamide is safe to take over a long period of time in children with epilepsy Ended
  2022-502639-21-00 Phase III 2 countries LACOSAMIDE
• An extension study to learn if Bimekizumab works and is safe over a long period in adults with Active Axial Spondyloarthritis. Ended
  2023-506527-28-00 Phase III 7 countries BIMEKIZUMAB
• A study to learn if Bimekizumab is safe and works over a long period in adults with Active Psoriatic Arthritis Ended
  2023-506528-95-00 Phase III 8 countries BIMEKIZUMAB

Showing 25–33 of 33 trials